- £1.43bn
- £730.76m
- £195.60m
- 91
- 60
- 64
- 86
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 319 | 342 | 301 | 255 | 196 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 114 | 128 | 34.6 | 135 | 116 |
Operating Profit | 205 | 214 | 267 | 119 | 79.8 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 220 | 222 | 283 | 118 | 112 |
Provision for Income Taxes | |||||
Net Income After Taxes | 182 | 185 | 242 | 91.9 | 86.5 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 179 | 182 | 240 | 88.5 | 83.3 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 179 | 182 | 240 | 88.5 | 83.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.25 | 0.257 | 0.342 | 0.126 | 0.121 |
Dividends per Share |